Liquidia Technologies Overview

  • Founded
  • 2004
Founded
  • Status
  • Public
  • Employees
  • 64
Employees
  • Stock Symbol
  • LQDA
Stock Symbol
  • Share Price
  • $2.99
  • (As of Tuesday Closing)

Liquidia Technologies General Information

Description

Liquidia Corp, formerly Liquidia Technologies Inc is a late-stage clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using PRINT technology to transform the lives of patients. PRINT technology is a particle engineering platform that enables the precise production of uniform drug particles designed to improve the safety, efficacy, and performance of a wide range of therapies. Liquidia is developing two product candidates from its own pipeline: LIQ861 for the treatment of pulmonary arterial hypertension (PAH) and LIQ865 for the treatment of local post-operative pain.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Therapeutic Devices
Other Pharmaceuticals and Biotechnology
Stock Exchange
NAS
Primary Office
  • 419 Davis Drive
  • Suite 100
  • Morrisville, NC 27560
  • United States
+1 (919) 000-0000

Liquidia Technologies Timeline

2018201920202021
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Liquidia Technologies Stock Performance

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.99 $2.97 $2.53 - $12.10 $129M 43.3M 1.17M -$2.09

Liquidia Technologies Financials Summary

In Thousands,
USD
TTM 30-Sep-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 182,915 95,434 299,720
Revenue 0 8,072 2,707 7,258
EBITDA (54,237) (44,256) (32,909) (15,212)
Net Income (58,169) (47,583) (53,136) (29,154)
Total Assets 91,111 68,842 49,418 14,844
Total Debt 18,937 24,416 12,773 22,146
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Liquidia Technologies Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Liquidia Technologies‘s full profile, request access.

Request a free trial

Liquidia Technologies Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Liquidia Technologies‘s full profile, request access.

Request a free trial

Liquidia Technologies Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Liquidia Corp, formerly Liquidia Technologies Inc is a late-stage clinical biopharmaceutical company focused on the deve
Drug Discovery
Morrisville, NC
64 As of 2019
00000
000000000 00000

000000 0

nim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis
0000 00000000
Bedford, MA
000 As of 0000
00000
00000000000 00000

0000000

commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu f
0000 000000000
Irvine, CA
00 As of 0000
00000
000000000 - 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Liquidia Technologies Competitors (14)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ocular Therapeutix Formerly VC-backed Bedford, MA 000 00000 00000000000 00000
0000000 Venture Capital-Backed Irvine, CA 00 00000 000000000 - 00000
0000000 0000000000 Corporation Leiden, Netherlands 00 0000000000
00000 Venture Capital-Backed Cambridge, United Kingdom 000 00000 000000&0 00000
000000 00000000000 Corporate Backed or Acquired Richmond, CA 000000000 -
You’re viewing 5 of 14 competitors. Get the full list »

Liquidia Technologies Executive Team (27)

Name Title Board Seat Contact Info
Neal Fowler Chief Executive Officer & Board Member
Damian DeGoa Chief Executive Officer
Michael Kaseta Chief Financial Officer
Steven Bariahtaris Chief Financial Officer, Finance
Robert Lippe Chief Operating Officer, Operations
You’re viewing 5 of 27 executive team members. Get the full list »

Liquidia Technologies Board Members (14)

Name Representing Role Since
Arthur Kirsch Self Board Member 000 0000
Joanna Horobin Liquidia Technologies Board Member 000 0000
Katherine Rielly-Gauvin Liquidia Technologies Board Member 000 0000
Neal Fowler Liquidia Technologies Chief Executive Officer & Board Member 000 0000
Raman Singh Self Board Member 000 0000
You’re viewing 5 of 14 board members. Get the full list »

Liquidia Technologies Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Liquidia Technologies Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Liquidia Technologies‘s full profile, request access.

Request a free trial